Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
- This program will challenge the laboratory to accurately identify the presence or absence
of alleles associated with a variety of disease states (listed below) and/or the adverse
reactions to specific drugs.
- Celiac disease
- Pemphigus Vulgaris
- Antiglomerular basement membrane disease
- Birdshot retinochoroidopathy
- Idiopathic myopathy
- Three 0.1‑mL specimens, each containing 200 µg/mL of human DNA in media
- Shipment A: April 12
Shipment B: August 23